EP3844297A4 - Peptides having immunomodulatory properties - Google Patents

Peptides having immunomodulatory properties Download PDF

Info

Publication number: EP3844297A4
Authority: EP; European Patent Office
Prior art keywords: peptides; immunomodulatory properties; immunomodulatory; properties
Prior art date: 2018-08-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

EP18931536.9A

Other languages

German (de)

French (fr)

Other versions

EP3844297A2 (en

Inventor

Jesse Jaynes

Henry Wilfred Lopez

George R. Martin

Clayton Yates

Charles Garvin

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Riptide Bioscience Inc

Original Assignee

Riptide Bioscience Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-08-29

Filing date

2018-08-29

Publication date

2022-08-31

2018-08-29 Application filed by Riptide Bioscience Inc filed Critical Riptide Bioscience Inc

2021-07-07 Publication of EP3844297A2 publication Critical patent/EP3844297A2/en

2022-08-31 Publication of EP3844297A4 publication Critical patent/EP3844297A4/en

Status Pending legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Rheumatology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Pain & Pain Management (AREA)
Genetics & Genomics (AREA)
Microbiology (AREA)
Mycology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EP18931536.9A 2018-08-29 2018-08-29 Peptides having immunomodulatory properties Pending EP3844297A4 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2018/048632 WO2020046297A2 (en)	2018-08-29	2018-08-29	Peptides having immunomodulatory properties

Publications (2)

Publication Number	Publication Date
EP3844297A2 EP3844297A2 (en)	2021-07-07
EP3844297A4 true EP3844297A4 (en)	2022-08-31

Family

ID=69645844

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP18931536.9A Pending EP3844297A4 (en)	2018-08-29	2018-08-29	Peptides having immunomodulatory properties

Country Status (8)

Country	Link
EP (1)	EP3844297A4 (en)
JP (2)	JP2022511280A (en)
KR (1)	KR20210052473A (en)
CN (1)	CN113039194A (en)
AU (1)	AU2018438604A1 (en)
CA (1)	CA3110618A1 (en)
WO (1)	WO2020046297A2 (en)
ZA (1)	ZA202101327B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20190224275A1 (en)	2017-05-12	2019-07-25	Aurinia Pharmaceuticals Inc.	Protocol for treatment of lupus nephritis
WO2022034523A1 (en) *	2020-08-13	2022-02-17	Immunitybio, Inc.	Phagocytosis-inducing compounds and methods of use

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20120270770A1 (en) *	2010-08-03	2012-10-25	Jesse Michael Jaynes	Anti-angiogenic peptides and their uses
WO2016061133A1 (en) *	2014-10-14	2016-04-21	Riptide Bioscience, Inc.	Peptides having anti-inflammatory properties

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020099008A1 (en) *	1999-04-26	2002-07-25	Daniel R. Twardzik	Method for stimulating hematopoiesis using tgf-alpha
EP1741790A1 (en) *	2005-03-24	2007-01-10	DIGILAB BioVisioN GmbH	Methods to identify and characterize prolyl oligopeptidases by using substrates and products thereof
WO2014139883A1 (en) *	2013-03-14	2014-09-18	Galapagos Nv	Molecular targets and compounds, and methods to identify the same, useful in the treatment of fibrotic diseases
US10017542B2 (en) *	2015-03-23	2018-07-10	Riptide Bioscience, Inc.	Antimicrobial peptides and methods of use thereof

2018
- 2018-08-29 EP EP18931536.9A patent/EP3844297A4/en active Pending
- 2018-08-29 CA CA3110618A patent/CA3110618A1/en active Pending
- 2018-08-29 WO PCT/US2018/048632 patent/WO2020046297A2/en unknown
- 2018-08-29 JP JP2021510646A patent/JP2022511280A/en active Pending
- 2018-08-29 AU AU2018438604A patent/AU2018438604A1/en active Pending
- 2018-08-29 CN CN201880098522.6A patent/CN113039194A/en active Pending
- 2018-08-29 KR KR1020217008293A patent/KR20210052473A/en not_active Application Discontinuation
2021
- 2021-02-26 ZA ZA2021/01327A patent/ZA202101327B/en unknown
2023
- 2023-07-28 JP JP2023123680A patent/JP2023145635A/en active Pending

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20120270770A1 (en) *	2010-08-03	2012-10-25	Jesse Michael Jaynes	Anti-angiogenic peptides and their uses
WO2016061133A1 (en) *	2014-10-14	2016-04-21	Riptide Bioscience, Inc.	Peptides having anti-inflammatory properties

Also Published As

Publication number	Publication date
KR20210052473A (en)	2021-05-10
CN113039194A (en)	2021-06-25
ZA202101327B (en)	2022-09-28
EP3844297A2 (en)	2021-07-07
JP2022511280A (en)	2022-01-31
AU2018438604A1 (en)	2021-03-18
WO2020046297A2 (en)	2020-03-05
CA3110618A1 (en)	2020-03-05
JP2023145635A (en)	2023-10-11

Legal Events

Date	Code	Title	Description
2020-03-07	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2021-06-04	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2021-06-12	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2021-07-07	17P	Request for examination filed	Effective date: 20210323
2021-07-07	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2021-12-08	DAV	Request for validation of the european patent (deleted)
2021-12-08	DAX	Request for extension of the european patent (deleted)
2022-04-27	RIC1	Information provided on ipc code assigned before grant	Ipc: C12Q 1/68 20180101AFI20220323BHEP
2022-08-31	A4	Supplementary search report drawn up and despatched	Effective date: 20220803
2022-08-31	RIC1	Information provided on ipc code assigned before grant	Ipc: C12Q 1/68 20180101AFI20220728BHEP

Publication	Publication Date	Title
EP3723783A4 (en)	2021-09-22	Mitochondria-targeting peptides
EP3369741A4 (en)	2019-09-18	Novel peptide
EP3814330A4 (en)	2022-07-20	Immunomodulatory compounds
EP3733686A4 (en)	2021-10-27	Novel peptide
EP3700558A4 (en)	2022-03-09	Tau peptide immunogen constructs
EP3746081A4 (en)	2021-10-27	Novel uses
EP3740228A4 (en)	2021-12-15	Peptides and uses thereof
EP3904701A4 (en)	2022-09-07	Clamp
EP3897128A4 (en)	2022-12-28	Antimicrobial peptides
ZA202101327B (en)	2022-09-28	Peptides having immunomodulatory properties
EP3802565A4 (en)	2022-09-14	Polypeptides
EP3760771A4 (en)	2021-11-24	Polyamide-610 multifilament
EP3688037A4 (en)	2021-09-15	Immunomodulatory fusion proteins
EP3653063A4 (en)	2021-03-24	Peptide
EP3866808A4 (en)	2023-04-12	Novel uses
AU2019350356A1 (en)	2021-04-15	Arginase1 polypeptides
EP3790394A4 (en)	2022-07-27	Aav-compatible laminin-linker polymerization proteins
EP3834079A4 (en)	2022-05-04	Multi-question multi-answer configuration
EP3725884A4 (en)	2021-10-13	Cell-membrane-permeable peptide
EP3703188A4 (en)	2021-07-21	Airtight terminal
EP3898652A4 (en)	2022-08-24	Mitochondria-targeting peptides
EP3986914A4 (en)	2023-07-19	Constrained peptides
EP3978511A4 (en)	2023-07-19	Norovirus-binding peptide
EP3978510A4 (en)	2023-10-18	Norovirus-binding peptide
EP3792349A4 (en)	2022-03-16	Peptide macrocyclase